Invesco Biotechnology & Genome ETF (PBE)

NYSEArca • Currently down 1.84 (-1.84%) in today's trading session

2 members of Congress have disclosed 2 trades in Invesco Biotechnology & Genome ETF (PBE) via STOCK Act filings. The most recent disclosure was a sale by Michael C. Burgess on 23 October 2014. The most active traders have been Michael C. Burgess (1) and Sheldon Whitehouse (1). Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).

Invesco Biotechnology & Genome ETF is currently trading at $98.43, positioned at 79% of its 52-week range ($75.50 – $104.69).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$98.43
24h Change
-1.84 (-1.84%)
52 Week Range
$75.50–$104.69
View on NASDAQ

Invesco Biotechnology & Genome ETF Price History and Technical Analysis

Congressional Trading Activity for PBE

Select to highlight on chart
2 transactions
Compliance: 0%
Michael C. Burgess23 Oct 20147 Aug 2015SaleStock$472N/A
Sheldon Whitehouse7 Jul 201413 Aug 2015SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$300.09M

Volume

3.47K

Beta

0.71

P/E Ratio

20.42

Fundamentals

EPS

$4.82

Div. Yield

1.57%

Open

$98.97

Day Range

$98.20 – $99.73

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
AMEX · USD
Country
US
IPO Date
2005-06-23
Website
www.invesco.com/us/en/financial-products/etfs/invesco-biotechnology-genome-etf.html

The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. Th...

No earnings data available for this stock.

Dividends

Dividend History

21 Sept 2026
Amount $0.0187
22 Jun 2026
Amount $0.8106
23 Mar 2026
Amount $0.0824
22 Dec 2025
Amount $0.4197
22 Sept 2025
Amount $0.2341
23 Jun 2025
Amount $0.1305
24 Mar 2025
Amount $0.0341
24 Jun 2024
Amount $0.0082
18 Mar 2024
Amount $0.0242
20 Jun 2023
Amount $0.0141
23 Mar 2020
Amount $0.0290
24 Sept 2018
Amount $0.0021
16 Jun 2017
Amount $0.2153
17 Mar 2017
Amount $0.0555
16 Dec 2016
Amount $0.1208
16 Sept 2016
Amount $0.0283
18 Dec 2015
Amount $0.3082
18 Sept 2015
Amount $0.1366
19 Jun 2015
Amount $0.1227
19 Sept 2014
Amount $0.0429
20 Jun 2014
Amount $0.2340
18 Dec 2009
Amount $0.0755

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about PBE

Which members of Congress have traded PBE?
2 members of Congress have disclosed 2 trades in Invesco Biotechnology & Genome ETF (PBE) under the STOCK Act. The most active traders are Michael C. Burgess and Sheldon Whitehouse.
When was PBE most recently disclosed by Congress?
The most recent PBE disclosure was a sale by Michael C. Burgess on 23 October 2014.
What is the total disclosed congressional trading volume for PBE?
Members of Congress have disclosed approximately $8K in PBE sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in PBE?
This PBE page updates as soon as new STOCK Act disclosures are filed for Invesco Biotechnology & Genome ETF. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.